Human IgG antibody Laboratories manufactures the sars cov2 spike protein mutation reagents distributed by Genprice. The Sars Cov2 Spike Protein Mutation reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact Spike Protein. Other Sars products are available in stock. Specificity: Sars Category: Cov2 Group: Spike Protein
CoV2 Nucleocapsid |
ProSpec Tany |
100µg |
EUR 275 |
Description: Polyclonal Rabbit Anti Full Length CoV2 Nucleocapsid |
CoV2 Paired |
ProSpec Tany |
50µg |
EUR 165 |
Description: Mouse Anti SARS CoV-2 Paired |
Mutation Quantification Control Plasma with 50 ng spike in DNA |
Biochain |
5 ml |
EUR 162 |
Mutation Quantification Control Plasma with 250 ng spike in DNA |
Biochain |
25 ml |
EUR 540 |
SARS-CoV2-N-Antibody |
EnoGene |
N/A |
EUR 276.5 |
Description: N/A |
SARS-CoV2-N-Antibody |
EnoGene |
N/A |
EUR 276.5 |
Description: N/A |
Spike Protein information
Ubiquitin Lys 48 to Arg 48 mutation Protein |
20-abx261722 |
Abbexa |
-
EUR 4236.00
-
EUR 393.60
-
EUR 276.00
|
|
|
SARS-CoV-2(COVID-19) Spike Recombinant Protein |
10-411 |
ProSci |
0.1 mg |
EUR 714.3 |
Description: Protein S (PROS1) is glycoprotein and expressed in many cell types supporting its reported involvement in multiple biological processes that include coagulation, apoptosis, cancer development and progression, and the innate immune response. Known receptors bind S1 are ACE2, angiotensin-converting enzyme 2, DPP4, CEACAM etc.. The spike (S) glycoprotein of coronaviruses is known to be essential in the binding of the virus to the host cell at the advent of the infection process. Most notable is severe acute respiratory syndrome (SARS). The severe acute respiratory syndrome-coronavirus (SARS-CoV) spike (S) glycoprotein alone can mediate the membrane fusion required for virus entry and cell fusion. It is also a major immunogen and a target for entry inhibitors. It's been reported that 2019-nCoV can infect the human respiratory epithelial cells through interaction with the human ACE2 receptor. The spike protein is a large type I transmembrane protein containing two subunits, S1 and S2. S1 mainly contains a receptor binding domain (RBD), which is responsible for recognizing the cell surface receptor. S2 contains basic elements needed for the membrane fusion.The S protein plays key parts in the induction of neutralizing-antibody and T-cell responses, as well as protective immunity. |
SARS-CoV-2 (COVID-19) Spike Recombinant Protein |
11-073 |
ProSci |
0.1 mg |
EUR 695.4 |
Description: May down-regulate host tetherin (BST2) by lysosomal degradation, thereby counteracting its antiviral activity. |
SARS-CoV-2 (COVID-19) Spike Recombinant Protein |
20-233 |
ProSci |
0.1 mg |
EUR 726.9 |
Description: SARS-CoV-2 (COVID-19) Spike Recombinant Protein |
SARS-CoV Spike Protein |
abx060655-1mg |
Abbexa |
1 mg |
EUR 2030.4 |
|
pPACK-SPIKE B.1.351 RBD Mutations, SARS-CoV-2 "S" Pseudotype - B.1.351 (S. African) Variant - RBD Mutations - Lentivector Packaging Mix |
CVD19-580A-1 |
SBI |
10 rxn |
EUR 677 |
SARS-CoV-2 (COVID-19) Spike S1 Recombinant Protein |
10-107 |
ProSci |
0.1 mg |
EUR 651.3 |
Description: The spike protein (S) of coronavirus (CoV) attaches the virus to its cellular receptor, angiotensin-converting enzyme 2 (ACE2). A defined receptor-binding domain (RBD) on S mediates this interaction. The S protein plays key parts in the induction of neutralizing-antibody and T-cell responses as well as protective immunity. |
SARS-CoV-2 (COVID-19) Spike S1 Recombinant Protein |
10-109 |
ProSci |
0.1 mg |
EUR 651.3 |
Description: The spike protein (S) of coronavirus (CoV) attaches the virus to its cellular receptor, angiotensin-converting enzyme 2 (ACE2). A defined receptor-binding domain (RBD) on S mediates this interaction. The S protein plays key parts in the induction of neutralizing-antibody and T-cell responses as well as protective immunity. |
SARS-CoV-2 (COVID-19) Spike S1 Recombinant Protein |
10-111 |
ProSci |
0.1 mg |
EUR 651.3 |
Description: The spike protein (S) of coronavirus (CoV) attaches the virus to its cellular receptor, angiotensin-converting enzyme 2 (ACE2). A defined receptor-binding domain (RBD) on S mediates this interaction. The S protein plays key parts in the induction of neutralizing-antibody and T-cell responses as well as protective immunity. |
SARS-CoV-2 (COVID-19) Spike S1 Recombinant Protein |
10-118 |
ProSci |
0.1 mg |
EUR 651.3 |
Description: SARS-CoV-2 (COVID-19) Spike S1 Recombinant Protein |
SARS-CoV-2 (COVID-19) Spike S1 Recombinant Protein |
10-207 |
ProSci |
0.1 mg |
EUR 651.3 |
Description: The spike protein (S) of coronavirus (CoV) attaches the virus to its cellular receptor, angiotensinconverting enzyme 2 (ACE2). A defined receptor-binding domain (RBD) on S mediates this interaction.The S protein plays key parts in the induction of neutralizing-antibody and T-cell responses, as well as protective immunity. |
SARS-CoV-2 (COVID-19) Spike S1 Recombinant Protein |
10-209 |
ProSci |
0.1 mg |
EUR 651.3 |
Description: The spike protein (S) of coronavirus (CoV) attaches the virus to its cellular receptor, angiotensinconverting enzyme 2 (ACE2). A defined receptor-binding domain (RBD) on S mediates this interaction.The S protein plays key parts in the induction of neutralizing-antibody and T-cell responses, as well as protective immunity. |
SARS-CoV-2 (COVID-19) Spike S1 Recombinant Protein |
10-300 |
ProSci |
0.1 mg |
EUR 632.4 |
Description: SARS-CoV-2 (COVID-19) Spike S1 Recombinant Protein |
SARS-CoV-2 (COVID-19) Spike S1 Recombinant Protein |
21-805 |
ProSci |
50 ug |
EUR 468.6 |
Description: SARS-CoV-2 shares 79.5% sequence identity with SARS-CoV and is 96.2% identical at the genome level to the bat coronavirus BatCoV RaTG133, suggesting it had originated in bats. The coronaviral genome encodes four major structural proteins: the Spike (S) protein, Nucleocapsid (N) protein, Membrane/Matrix (M) protein and the Envelope (E) protein. The SARS Envelope (E) protein contains a short palindromic transmembrane helical hairpin that seems to deform lipid bilayers, which may explain its role in viral budding and virion envelope morphogenesis. The SARS Membrane/Matrix (M) protein is one of the major structural viral proteins. It is an integral membrane protein involved in the budding of the viral particles and interacts with SARS Spike (S) protein and the Nucleocapsid (N) protein. The N protein contains two domains, both of them bind the virus RNA genome via different mechanisms.The CoV Spike (S) protein assembles as trimer and plays the most important role in viral attachment, fusion and entry. It is composed of a short intracellular tail, a transmembrane anchor and a large ectodomain that consists of a receptor binding S1 subunit (RBD domain) and a membrane-fusing S2 subunit. The S1 subunit contains a receptor binding domain (RBD), which binds to the cell surface receptor angiotensin-converting enzyme 2 (ACE2) present at the surface of epithelial cells. |
SARS-CoV-2 (COVID-19) Spike S1 Recombinant Protein |
21-807 |
ProSci |
50 ug |
EUR 437.1 |
Description: SARS-CoV-2 shares 79.5% sequence identity with SARS-CoV and is 96.2% identical at the genome level to the bat coronavirus BatCoV RaTG133, suggesting it had originated in bats. The coronaviral genome encodes four major structural proteins: the Spike (S) protein, Nucleocapsid (N) protein, Membrane/Matrix (M) protein and the Envelope (E) protein. The SARS Envelope (E) protein contains a short palindromic transmembrane helical hairpin that seems to deform lipid bilayers, which may explain its role in viral budding and virion envelope morphogenesis. The SARS Membrane/Matrix (M) protein is one of the major structural viral proteins. It is an integral membrane protein involved in the budding of the viral particles and interacts with SARS Spike (S) protein and the Nucleocapsid (N) protein. The N protein contains two domains, both of them bind the virus RNA genome via different mechanisms.The CoV Spike (S) protein assembles as trimer and plays the most important role in viral attachment, fusion and entry. It is composed of a short intracellular tail, a transmembrane anchor and a large ectodomain that consists of a receptor binding S1 subunit (RBD domain) and a membrane-fusing S2 subunit. The S1 subunit contains a receptor binding domain (RBD), which binds to the cell surface receptor angiotensin-converting enzyme 2 (ACE2) present at the surface of epithelial cells.The SARS-CoV-2 Spike Protein S1 (RBD) (rec.) (His) is used as antigen in the Serological ELISA Kit to detect anti-SARS-CoV-2 Spike (RBD) antibodies in serum or plasma (see SARS-CoV-2 (Spike RBD) IgG Serological ELISA Kit; AG-45B-0020). |
pPACK-SPIKE B.1.351 RBD Mutations, SARS-CoV-2 "S" Pseudotype - B.1.351 (S. African) Variant - RBD Mutations - Lentivector Packaging Mix (XL) |
CVD19-585A-1 |
SBI |
25 rxn |
EUR 1349 |
SARS-CoV-2 (COVID-19) Spike RBD Recombinant Protein |
10-100 |
ProSci |
0.1 mg |
EUR 651.3 |
Description: The spike protein (S) of coronavirus (CoV) attaches the virus to its cellular receptor, angiotensin-converting enzyme 2 (ACE2). A defined receptor-binding domain (RBD) on S mediates this interaction. The S protein plays key parts in the induction of neutralizing-antibody and T-cell responses as well as protective immunity. |